FIOCRUZ Receives Regulatory Approval to Market Chembio DPP HIV 1/2 Confirmatory Test

[NewsWhore]

CEMI ), which develops, manufactures, markets and licenses point-of-care diagnostic tests, has been notified that Bio-Manguinhos, a division of the Oswaldo Cruz Foundation of Brazil ("FIOCRUZ"), has r...

More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/38914778/)